drugset / Trial / NCT00799448
Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Europe. The aim of this trial is to compare the efficacy and safety of repaglinide combined with insulin NPH versus biphasic human insulin 30 alone in type 2 diabetics inadequately controlled with sulfonylurea (SU) +/ biguanide therapy
Timeline
- Start
- 2003-09-16
- Primary completion
- 2004-09-20
- Completion
- 2004-09-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Repaglinide | Small molecule | — | — |
| Subject | biphasic human insulin 30 | Unknown | — | — |
| Subject | insulin NPH | Protein / enzyme biologic | — | — |